Characterization of the interactions of β-amyloid peptides with glycolipid receptors by surface plasmon resonance

Spectroscopy

Volumn 17, Issue 2-3, 2003, Pages 241-254

  Valdes Gonzalez, Tania ^a   Inagawa, Junichi ^b   Ido, Tatsuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b Biacore KK   (Japan)

Author keywords

A deposition; Gangliosides; Surface plasmon resonance

Indexed keywords

CELL MEMBRANES; CHEMICAL ACTIVATION; CHEMICAL BONDS; DISEASES; LIPIDS; NEUROLOGY; PH; RATE CONSTANTS; SURFACE PLASMON RESONANCE; SURFACE REACTIONS;

SENSOGRAMS;

BIOLOGICAL MATERIALS;

AMYLOID BETA PROTEIN; CELL SURFACE RECEPTOR; DIMYRISTOYLPHOSPHATIDYLCHOLINE; GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GT 1B; GLYCOLIPID; LIPOSOME;

ALZHEIMER DISEASE; BINDING AFFINITY; CONFERENCE PAPER; DISSOCIATION CONSTANT; KINETICS; NERVE CELL MEMBRANE; NEUROPATHOLOGY; PEPTIDE ANALYSIS; PH; SENILE DEMENTIA; SURFACE PLASMON RESONANCE;

EID: 0037544310     PISSN: 07124813     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/185737     Document Type: Conference Paper

References (28)

1. G.C. Glenner and C.W. Wong, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Comm. 120 (1984), 885-890.
2. J. Kang, H.-G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grezeschik, G. Multhaup, K. Beyreuther and B. Muller-Hill, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature 325 (1987), 733-736.
3. D. Goldgaber, M.I. Lerman, O.W. McBride, U. Saffiotti and D.C. Gajdusek, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease, Science 235 (1987), 877-880.
4. E. Terzi, G. Holzemann and J. Seeling, Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes, Biochem. 33 (1994), 7434-7441.
5. E. Terzi, G. Holzemann and J. Seeling, Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes, J. Mol. Biol. 252 (1995), 633-642.
6. N. Arispe, H.B. Pollard and E. Rojas, Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes, Proc. Natl. Acad. Sci. USA 90 (1993), 10 573-10 577.
7. 2+ interaction with Alzheimer amyloid protein calcium channels, Proc. Natl. Acad. Sci. USA 93 (1996), 1710-1715.
8. M. Kawara, N. Arispe, Y. Kuroda and E. Rojas, Alzheimer's - amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic gnrh neuronal cell line, J. Biol. Chem. 275 (2000), 14 077-14 083.
9. 2+-sensitive, selective cation channels across excised membrane patches from hypothalamic neurons, J. Biophys. 73 (1997), 67-75.
10. J. MacLaurin and A.J. Chakrabatty, Membrane disruption by Alzheimer - amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity, J. Biol. Chem. 271 (1996), 26 482-26 489.
11. J. MacLaurin, T. Franklin, P. Fraser and A. Chakrabatty, Structural transitions associated with the interaction of Alzheimer - amyloid peptides with gangliosides, J. Biol. Chem. 273 (1998), 4506-4515.
12. L. Choo-Smith, W. Garzon-Rodriguez, C. Glabe and W.K. Surewicz, Acceleration of amyloid fibril formation by specific binding of A(1-40) peptide to ganglioside-containing membrane vesicles, J. Biol. Chem. 272 (1997), 22 987-22 990.
13. K. Matsuzaki and C. Horikiri, Interactions of amyloid beta-peptide (1-40) with ganglioside-containing membranes, Biochem. 38 (1999), 4137-4142.
14. Y. Nagai, Functional roles of gangliosides in bio-signaling, Behav. Brain Res. 66 (1995), 99-104.
15. P.D. Thomas and G.J. Brewer, Gangliosides and synaptic transmission, Biochim. Biophys. Acta 1031 (1990), 277-289.
16. H. Wiegandt, The chemical constitution of gangliosides of the vertebrate nervous system, Behav. Brain Res. 66 (1995), 85-97.
17. G.M. Kuziemko, M. Stroh and R.C. Stevens, Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance, Biochem. 35 (1996), 6375-6384.
18. B. Harrinson, R. MacKenzie, T. Hirama, K.K. Lee and E. Altman, A kinetic approach to the characterization of an IgM specific for the glycolipid asialo-GM1, J. Immunol. Meth. 212 (1998), 29-30.
19. T. Valdes-Gonzalez, J. Inagawa and T. Ido, Neuropeptides interact with glycolipid receptors a surface plasmon resonance study, Peptides 22 (2001), 1099-1105.
20. L.K. Simmons, P.C. May, K.J. Tomaselli, R.E. Rydel, K.S. Fuson, E.F. Brigham, S. Wright, I. Lieberburg, G.W. Becker, D.N. Brems and W.Y. Li, Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol. 45 (1994), 373-379.
21. R. MacKenzie, T. Hirama, K. Lee, E. Altman and N.M. Young, Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance, J. Biol. Chem. 272 (1997), 5533-5538.
22. L.K. Simmons, P.C. May, K.J. Tomaselli, R.E. Rydel, K.S. Fuson, E.F. Brigham, S. Wright, I. Lieberburg, G.W. Becker, D.N. Brems and W.Y. Li, Mol. Pharmcol. 45 (1993), 373-379.
23. M. Gonzalez, N. Lezcano, M. Celis and D. Fidelio, Interactions of alpha-MHS and substance P with interfaces containing gangliosides, Peptides 17 (1996), 269-274.
24. P.B. Crino, M.D. Ullman, B.A. Vogt, E.D. Bird and L. Volicer, Brain gangliosides in dementia of the Alzheimer type, Arch. Neurol. 46 (1989), 398-401.
25. I. Kracun, S. Kalanj, J. Talan-Hranilovic and Cosovic, Cortical distribution of gangliosides in Alzheimer's disease, Neurochem. Int. 20 (1992), 433-438.
26. L. Svennerholm and C. Gottfries, Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II), J. Neurochem. 62 (1994), 1039-1047.
27. T. Valdes-Gonzalez, Y. Morita, K. Suzuki and T. Ido, Excitotoxicity induces changes in rat brain gangliosides, Neuroscience Res. 39 (2001), 197-203.
28. H. Rahamann, Brain gangliosides and memory formation, Brain Res. 66 (1995), 105-116.